Prosecution Insights
Last updated: April 19, 2026

Examiner: HARVEY-BUTLER, AVANDA ELEXA

Tech Center 1600 • Art Units: 1683

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
9
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

14.3%
§101 Eligibility
0%
§102 Novelty
40.5%
§103 Obviousness
33.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18325610 COMPOSITIONS AND METHODS FOR NUCLEIC ACID SEQUENCING Non-Final OA Illumina, Inc.
18356933 DECOY OLIGONUCLEOTIDES AND RELATED METHODS Non-Final OA 10x Genomics, Inc.
18215299 COVALENT ATTACHMENT OF SPLINT OLIGONUCLEOTIDES FOR MOLECULAR ARRAY GENERATION USING LIGATION Non-Final OA 10x Genomics, Inc.
18342906 COMPOSITIONS AND METHODS FOR GENERATING MOLECULAR ARRAYS USING OLIGONUCLEOTIDE PRINTING AND PHOTOLITHOGRAPHY Non-Final OA 10x Genomics, Inc.
18320837 MVP CARTRIDGE AND METHODS OF USE AND MANUFACTURE Non-Final OA Cepheid
18322595 DETECTION METHOD OF AMMONIA OXIDATION FUNCTIONAL GENE IN WATER TREATMENT Non-Final OA Chung Yuan Christian University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month